Inve US ▾
PRPRVA

Privia Health (PRVA) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 6, 2026

Source: earnings call transcript

Executive summary

Privia Health Q2 FY26 — Strong Growth and Raised Full-Year Outlook

Privia Health delivered a strong Q2 FY26, driven by robust provider and attributed lives growth, leading to a 29% increase in adjusted EBITDA and significant margin expansion. The company raised its full-year outlook across all key financial metrics, reflecting confidence in its execution and diversified value-based care model. Management highlighted the continued expansion of its national footprint and the strategic deployment of AI applications to enhance operational efficiency and drive further margin accretion.

Highlights

5
  • Implemented provider growth of 10.1% year-over-year to 5,644.

  • Value-based attributed lives growth of 19.2% year-over-year to 1.64 million.

  • Adjusted EBITDA increased 29% year-over-year to $37.4 million.

  • EBITDA margin as a percentage of care margin expanded 310 basis points to 28.3%.

  • Raised 2026 outlook across all key financial metrics, with attributed lives above prior guidance.

Concerns

2
  • Potential delay in CMS Medicare Shared Savings Program cash settlement for 2025 performance until November.

  • Implied deceleration in practice collections growth from 13.4% in 1H to approximately 3% in 2H, attributed by management to prudence.

Guidance & targets

CategoryTargetConfidence
Full-year 2026 Practice Collections
High end of prior guidance range
medium materiality
Medium
Full-year 2026 GAAP Revenue
High end of prior guidance range
medium materiality
Medium
Full-year 2026 Care Margin
Mid- to high end of prior guidance range
medium materiality
Medium
Full-year 2026 Platform Contribution
Mid- to high end of prior guidance range
medium materiality
Medium
Full-year 2026 Adjusted EBITDA
Mid- to high end of prior guidance range
medium materiality
Medium
Full-year 2026 Attributed Lives
Above the high end of prior guidance
medium materiality
Medium
Full-year 2026 Implemented Providers
570 providers at midpoint
medium materiality
Medium
Long-term EBITDA margin as % of care margin
Expand towards the high end of 30% to 35%
high materiality
Medium
Full-year 2026 Free Cash Flow Conversion
70% to 80% of full year adjusted EBITDA
medium materiality
Medium

Deals & partnerships

Urology Group of Bergen County Entry into the state of New Jersey

Partnership with a practice of 25 adult and pediatric clinicians, representing Privia's 25th state. Expected to be a 5-10 year play to build local density.

Risks & headwinds

Delay in CMS Medicare Shared Savings Program cash settlement Q4 FY26

Delivery of final reconciliation results for performance year 2025 may be delayed until November.

Mitigation:Management is confident in receiving the money, viewing it as a timing issue (30-45 days delay) due to proposed changes, not a concern about payment. It has minimal impact on accruals.

What to watch in Q3 FY26

CMS Shared Savings Cash Settlement

Q4 FY26
Current Delayed until November for 2025 performance year
Target Receipt of cash settlement by year-end

Why it matters

Impacts year-end cash flow dynamics and free cash flow conversion.

While this has minimal impact on our accruals, it may lead to an atypical year-end cash flow dynamic, depending on when we receive the cash settlement from CMS as well as our subsequent payments to the providers.

Find out whether PRVA delivers this. Inve re-checks your case every morning.

Q&A highlights

What gives you confidence that the delayed CMS shared savings payment will come in Q4, and what external signposts should we watch?

Management expressed confidence, noting CMS has been reliable in the past. The delay is due to proposed changes, not a concern about payment, and is expected to be 30-45 days. They believe it's in CMS's interest to ensure providers receive cash flow for good performance.

“I mean we're not that worried about it. They've been really good over the past many years. Usually, results come in August, September. The cash settlement happens sometime October. So it's delayed by, call it, 30 to 45 days.”

asked by Elizabeth Anderson · answered by Parth Mehrotra

2 min read 6 chapters

Detailed narrative

Strong Operational Execution and Growth

Privia Health continued its strong execution, delivering significant growth in implemented providers and attributed lives. The company's footprint expanded to 25 states and D.C., with 5,644 implemented providers and 1.64 million attributed lives, demonstrating consistent growth and market penetration. Gross provider retention averaged 98% over the past three years, contributing to predictable business performance.

Value-Based Care Expansion and Impact

The company serves over 1.64 million attributed lives across more than 130 commercial and government value-based care programs, managing an estimated $15.7 billion in total medical spend. Diversification across commercial, Medicare, and Medicaid programs provides confidence in scaling profitability without reliance on a single program. Management highlighted the ability to transform fee-for-service payments into multi-set payments, including care management fees and shared savings.

AI Integration for Efficiency and Margin Expansion

Privia is actively deploying AI applications across various workflows, including corporate functions, fee-for-service, value-based care, and patient experience. This initiative is expected to drive further EBITDA margin expansion towards the high end of the 30-35% long-term target by improving efficiency, reducing administrative tasks, and limiting headcount growth. The company is piloting various applications and measuring tangible benefits in time saved and outcomes achieved.

Strategic Market Entry and Acquisitions

The entry into New Jersey in partnership with the Urology Group of Bergen County, a practice with 25 clinicians, marks the 25th state for Privia, reinforcing its national primary care-centric network strategy. Recent acquisitions like Evolent and IMS are progressing well, contributing to growth and expanding the company's capabilities, particularly in the ACO-only model, which allows for broader market conversations and potential tuck-in acquisitions.

Prudent Guidance and Future Outlook

Management raised its 2026 outlook across all key financial metrics, including practice collections, care margin, and EBITDA, reflecting strong first-half performance. While the implied H2 growth rate for practice collections suggests deceleration, management attributes this to prudence and anticipates potential upside if current trends continue. The company maintains a robust pipeline for existing market expansion and new opportunities.

Strengthening Physician Value Proposition

Privia's value proposition for physicians continues to strengthen, offering better fee-for-service contract rates, significant expense savings on technology, and efficiency gains, leading to a 10-20% productivity lift. The sophisticated value-based care machinery allows providers to participate across the entire patient panel, transforming payments and enabling organic practice growth, with some practices doubling in size over 5-7 years.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.